Delivery Order SPE2DB24D2106-SPE2DB24FAUBY

Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,916.25 firm fixed-price award is for the delivery of YUVAFEM 10 MCG vaginal inserts. The award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle, under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,813.40 delivery order is for the provision of YUVAFEM 10 MCG vaginal inserts. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,650.90 contract is for the provision of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,659.73 contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award, valued at $9,104.55, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,906.93, is for the delivery of 4564788297 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and...
This federal contract award, with a ceiling value of $5,970.80, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 8S, a medical product, to support federal healthcare programs, particularly for military personnel and veterans. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of YUVAFEM 10 MCG vaginal inserts to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,447.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 22, 2024, with a completion date of November 25, 2024. This award is a task order under a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S medical products to the Defense Logistics Agency (DLA). The $1,084.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of YUVAFEM 10 MCG vaginal inserts to the Defense Logistics Agency (DLA). The $4,767.91 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 9, 2025, with a completion date of February 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB24FAUBY
    Delivery Order

The federal contract award is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a ceiling value of $1,961.01 and a completion date of April 17, 2024. The contract is not set aside and is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

Generated 7/16/24, 1:07 PM